2nd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$130,674
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Graduate Medical Education; Resident Physician Shortage Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); White House Office; Government Accountability Office (GAO); Office of Management & Budget (OMB); Executive Office of the President (EOP); Food & Drug Administration (FDA)

Budget/Appropriations BUD

National Health Service Corp; Community Health Centers; Health Resource & Services Administration

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); SENATE; White House Office; Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA)

Insurance INS

Professional Liability Insurance; Health Insurance

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Centers For Disease Control & Prevention (CDC)

Medical/Disease Research/Clinical Labs MED

NIH, FDA

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Office of Management & Budget (OMB); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA)

Torts TOR

Protecting Access to Care Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Medicare Payment Advisory Commission (MedPAC); White House Office; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB)

Taxation/Internal Revenue Code TAX

Health Savings Accounts; Primary Care Enhancement Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); White House Office; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Government Accountability Office (GAO); Food & Drug Administration (FDA)

Health Issues HCR

Medicare Physician Payment Reform; Physician Workforce

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); White House Office; Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Food & Drug Administration (FDA)

Education EDU

Teaching Health Center Graduate Medical Education; National Health Service Corps; Foreign Medical School Accountability Fairness Act; Single Accreditation

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; White House Office; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.